Many people with GPP also have plaque psoriasis and other co-occurring conditions ... Used primarily for the management of mild GPP or in combination with other treatments for severe GPP, topical ...

The latest FDA approval was based on the results of the ADVANCE trial, which showed that five times as many adults with mild to moderate plaque psoriasis receiving oral Otezla 30 mg twice daily ...

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...

The company aims to soon launch two tests to aid the treatment of dermatomycosis and is developing other tests for healthcare ...

The company noted that the results further support the role of Sotyktu, the first TYK2 inhibitor available for patients living with moderate-to-severe plaque psoriasis, as a potential oral ...

Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the ...

Omega 3 fatty acids are some of the most critical nutrients which help humans remain healthy. They are well known for helping ...

J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...